Medicare Enrolled

Dr. Jennifer Dharamsi, M.D.

Dermatology · Frisco, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3140 LEGACY DRIVE, Frisco, TX 75034
9724692626
In practice since 2008 (17 years)
NPI: 1255507794 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dharamsi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dharamsi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dharamsi

Dr. Jennifer Dharamsi is a dermatology specialist in Frisco, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Dharamsi performed 4,322 Medicare services across 2,258 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dharamsi received a total of $6,750 from 42 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dharamsi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 28% volume in TX $6,750 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,322
Medicare services
Top 28% in TX for dermatology
2,258
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~254 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 1,333 $5 $13
Destruction of skin growths (warts/lesions), 1-14 508 $81 $221
Office visit, established patient (20-29 min) 503 $61 $176
Destruction of precancerous skin growth, 1 430 $32 $131
Office visit, established patient (30-39 min) 409 $87 $248
Skin biopsy, tangential 265 $59 $198
Destruction of precancer skin growth, 15 or more growths 138 $119 $329
Office visit, established patient (10-19 min) 104 $37 $110
Steroid injection (triamcinolone) 103 $1 $2
Biopsy of related skin growth, each additional growth 101 $39 $98
New patient office visit (45-59 min) 78 $110 $324
New patient office visit (30-44 min) 74 $74 $217
Injection into skin growth, 1-7 growths 48 $30 $111
Destruction of skin growth, 15 or more growths 33 $93 $258
Acne surgery 31 $82 $226
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm 29 $328 $830
Simple or single drainage of skin abscess 27 $92 $244
Injection into skin growth, more than 7 growths 26 $45 $136
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 21 $105 $476
Punch biopsy, first skin growth 17 $91 $245
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm 16 $116 $544
Biopsy of ear 14 $51 $188
New patient office or other outpatient visit, 15-29 minutes 14 $32 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
13.3% medium
86.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,750
Total received (2018-2024)
Avg $964/year across 7 years
Top 37% in TX for dermatology
42
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,750 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,234
2023
$534
2022
$684
2021
$218
2020
$609
2019
$1,822
2018
$1,649

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$672
ABBVIE INC.
$606
Novartis Pharmaceuticals Corporation
$423
Regeneron Healthcare Solutions, Inc.
$342
Galderma Laboratories, L.P.
$340
Allergan Inc.
$334
LEO Pharma Inc.
$324
Ortho Dermatologics, a division of Bausch Health US, LLC
$303
Sun Pharmaceutical Industries Inc.
$296
Lilly USA, LLC
$259
GENZYME CORPORATION
$240
AbbVie, Inc.
$220
Merz North America, Inc.
$217
Janssen Biotech, Inc.
$203
AbbVie Inc.
$202
Mayne Pharma Inc.
$169
Boston Scientific Corporation
$150
PruGen, Inc. Pharmaceuticals
$137
Journey Medical Corporation
$136
Dermavant Sciences, Inc.
$116
Celgene Corporation
$95
Incyte Corporation
$92
PFIZER INC.
$80
E.R. Squibb & Sons, L.L.C.
$80
Pierre Fabre Pharmaceuticals, Inc.
$79
Amgen Inc.
$77
Sensus Healthcare, Inc.
$63
UCB, Inc.
$60
Novum Pharma, LLC
$58
DERMIRA, INC.
$57
Almirall LLC
$56
SUN PHARMACEUTICAL INDUSTRIES INC.
$47
Aclaris Therapeutics, Inc.
$34
MAYNE PHARMA INC.
$34
EPI Health, LLC
$33
Exeltis, USA Inc.
$25
Arcutis Biotherapeutics, Inc.
$20
MIMEDX Group, Inc.
$17
Promius Pharma LLC
$16
Medimetriks Pharmaceuticals, Inc.
$15
STRATA Skin Sciences, Inc.
$13
Mylan Pharmaceuticals Inc.
$12
Top 3 companies account for 25.2% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · Absorica LD · Aczone · Alcortin A · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · COSENTYX · Cabtreo · Ceracade · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · Cloderm Cream · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DYSPORT · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Ecoza · Exelderm · HUMIRA · Humira · ILUMYA · JUBLIA · NATRELLE SALINE-FILLED BREAST IMPLANTS · Neo-Synalar Cream Kit · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · ULTRAVATE · VTAMA · WaveWriter Alpha Prime 16 · Winlevi · XTRAC · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $156 per 100 Medicare services performed
Looking for a dermatology specialist in Frisco?
Compare dermatologists in the Frisco area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
205
Per 100K population
18.4
County median income
$117,588
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER - FRISCO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dharamsi is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dharamsi experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Dharamsi performed 1,333 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dharamsi receive payments from pharmaceutical companies?
Yes. Dr. Dharamsi received a total of $6,750 from 42 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dharamsi's costs compare to other dermatologists in Frisco?
Dr. Dharamsi's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dharamsi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →